Huntington National Bank Has $17.94 Million Stock Position in Colgate-Palmolive (NYSE:CL)

Huntington National Bank boosted its position in shares of Colgate-Palmolive (NYSE:CL - Free Report) by 10.3% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 172,829 shares of the company's stock after acquiring an additional 16,121 shares during the period. Huntington National Bank's holdings in Colgate-Palmolive were worth $17,941,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in CL. Price T Rowe Associates Inc. MD raised its position in Colgate-Palmolive by 27.8% in the first quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company's stock worth $3,698,096,000 after purchasing an additional 8,933,912 shares in the last quarter. Swedbank AB bought a new position in shares of Colgate-Palmolive during the first quarter valued at $286,370,000. Acadian Asset Management LLC boosted its position in Colgate-Palmolive by 108.4% in the second quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company's stock valued at $551,367,000 after buying an additional 2,955,442 shares in the last quarter. Massachusetts Financial Services Co. MA boosted its holdings in shares of Colgate-Palmolive by 40.7% in the 2nd quarter. Massachusetts Financial Services Co. MA now owns 8,969,498 shares of the company's stock worth $870,400,000 after acquiring an additional 2,593,313 shares in the last quarter. Finally, Ossiam grew its position in Colgate-Palmolive by 368.4% during the 1st quarter. Ossiam now owns 1,563,768 shares of the company's stock worth $140,817,000 after acquiring an additional 1,229,891 shares during the last quarter. Institutional investors and hedge funds own 80.41% of the company's stock.

Wall Street Analyst Weigh In

CL has been the topic of several research analyst reports. JPMorgan Chase & Co. increased their target price on Colgate-Palmolive from $113.00 to $114.00 and gave the stock an "overweight" rating in a report on Friday, October 11th. HSBC restated a "hold" rating on shares of Colgate-Palmolive in a research report on Friday, July 26th. Piper Sandler assumed coverage on shares of Colgate-Palmolive in a research note on Tuesday, September 24th. They set an "overweight" rating and a $121.00 price target on the stock. Sanford C. Bernstein raised their price target on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the company a "market perform" rating in a report on Tuesday, July 30th. Finally, TD Cowen reduced their price objective on Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating on the stock in a report on Monday, October 28th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of "Moderate Buy" and a consensus target price of $105.11.

Colgate-Palmolive Trading Up 2.3 %

Shares of NYSE:CL traded up $2.13 during mid-day trading on Friday, reaching $93.58. The stock had a trading volume of 7,328,850 shares, compared to its average volume of 4,387,812. The firm has a market cap of $76.46 billion, a PE ratio of 26.22, a price-to-earnings-growth ratio of 3.25 and a beta of 0.42. The firm has a 50 day simple moving average of $99.60 and a two-hundred day simple moving average of $98.43. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a twelve month low of $75.17 and a twelve month high of $109.30.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be paid a $0.50 dividend. The ex-dividend date of this dividend is Friday, October 18th. This represents a $2.00 dividend on an annualized basis and a yield of 2.14%. Colgate-Palmolive's payout ratio is 57.31%.

Insider Buying and Selling

In related news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the transaction, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. This represents a 16.44 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.34% of the stock is owned by company insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.